P. Martin Paslick - 23 Jan 2023 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
SVP and CIO
Signature
/s/ Natalie Harrison Cline, Attorney-in-Fact
Issuer symbol
HCA
Transactions as of
23 Jan 2023
Net transactions value
-$290,700
Form type
4
Filing time
25 Jan 2023, 18:03:15 UTC
Previous filing
23 Feb 2022
Next filing
01 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Options Exercise $491,760 +6,000 +31% $81.96 25,112 23 Jan 2023 Direct F1
transaction HCA Common Stock Tax liability $782,460 -2,966 -12% $263.81 22,146 23 Jan 2023 Direct F1
holding HCA Common Stock 60,000 23 Jan 2023 By PMP 2020 Trust
holding HCA Common Stock 63,999 23 Jan 2023 by RJP 2020 Trust
holding HCA Common Stock 4,000 23 Jan 2023 by 2021 Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Options Exercise $0 -6,000 -33% $0.000000 12,340 23 Jan 2023 Common Stock 6,000 $81.96 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018.